IFIH1 and interstitial lung disease: The clinical characteristics of progressive fibrosis in patients with myositis-specific antibody-positive interstitial pneumonia (MSA-IP) have been described by clustering in our previous studies and demonstrated that anti-MDA5 positive and acute or subacute of ILD patients were prone to interstitial pneumonia progression (12).